European venture capital fund
InnoBio 3 InnoBio 3 is a Paris-based venture capital fund managed by Bpifrance. €207m reported at final close (source published September 2026).
Backs innovative biotech companies with differentiated assets through a partnership model linking pharma groups, investors and scientific experts.
Status Final Close
Reported amount €207m
Manager Bpifrance
Headquarters Paris, France
Stages Seed, Series A, Series B, Series C
Sectors Health & Bio
Source published September 2026 Amounts come from the linked public source. A first close is not the final fund size, and a reported close does not confirm that the fund is investing now. Headquarters describe where the manager is based, not where it invests.
All funds News Who it is for Methodology Contact Guides + − Not investment advice. Based on public sources; confirm current details with the manager.
Built by Kai Marek with AI assistance.
Legal notice Privacy policy